NICE lipid modification guidance: more questions than answers?
Authors
Abstract
NICE recently published its long‐awaited guidance on lipid modification in primary and secondary prevention of cardiovascular disease and in type 2 diabetes. Here, Dr Martin Duerden gives his interpretation of the guidance and discusses the health resource implications. Copyright © 2008 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.266 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
